Clinical Report: Isolation and Expansion of CD25+CD27+CD70− Tregs

Overview

This study presents a novel method for isolating and expanding CD25+CD27+CD70− alloantigen-specific regulatory T cells (AS-Tregs), achieving a 434-fold expansion with over 95% purity. The expanded Tregs maintain functional stability and lineage fidelity, suggesting their potential for enhancing transplant tolerance.

Background

Regulatory T cells (Tregs) are essential for achieving immune tolerance in transplantation, as they suppress conventional T cells and modulate antigen-presenting cell activity. The clinical application of alloantigen-specific Tregs (AS-Tregs) has been limited by their low frequency and instability during ex vivo expansion. Developing effective methods for Treg isolation and expansion could significantly improve transplant outcomes and reduce reliance on systemic immunosuppression.

Data Highlights

Key Findings

• CD25+CD27+CD70− AS-Tregs can be isolated and expanded with high purity and functional stability.
• The expansion protocol resulted in a 434-fold increase in Treg numbers over three weeks.
• Expanded Tregs maintained >60% FOXP3-TSDR demethylation, indicating stable lineage commitment.
• CD27+ AS-Tregs exhibited a robust immunoregulatory phenotype with high expression of Helios, CTLA-4, and CD39.
• These Tregs suppressed T cell proliferation in an antigen-specific manner, even in inflammatory conditions.

Clinical Implications

The successful isolation and expansion of CD25+CD27+CD70− AS-Tregs may provide a stable and effective therapeutic option for promoting transplant tolerance. This approach could reduce the need for systemic immunosuppression, potentially improving patient outcomes in transplantation.

Conclusion

The findings support the potential of CD27+ AS-Tregs as a promising candidate for long-term Treg therapy in transplantation, offering a stable solution for enhancing allograft tolerance.

Related Resources & Content

1. Bone Marrow Transplantation, 2025 -- Treg Cell Therapy as a Treatment for Graft-versus-Host Disease
2. Frontiers in Immunology, 2026 -- CD8 regulatory T cells are a novel type regulatory T cells in the induction of transplantation immune tolerance
3. Bone Marrow Transplantation, 2021 -- Depletion of CD276+ Cells from Haploidentical Memory T-Cell Grafts Reduces GVHD Risk
4. Transplant Recipient – KDIGO, 2026 -- Care of Kidney Transplant Recipients
5. Journal of Crohn's and Colitis — IL23R-Specific CAR Tregs for the Treatment of Crohn’s Disease
6. Pharmacokinetics, lineage identity, and trafficking of ex vivo expanded polyclonal regulatory T cells in a prospective randomized clinical trial of kidney transplant recipients with allograft inflammation
7. Study Design: Human Leukocyte Antigen Class I Molecule A∗02-Chimeric Antigen Receptor Regulatory T Cells in Renal Transplantation
8. Transplant Recipient – KDIGO